In the cause of study a new drug for renal carcinoma, the authors search for the presence of a tumor-initiating stem cell population in renal carcinomas [52], they separated the renal tumor cells and used the mesenchymal stem cell marker CD105 from human renal carcinomas. The gene discussed is ENG; the disease is renal carcinoma.